Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Will $2.5Bn Jury Verdict Against Gilead Stand? Future Royalties, Willful Infringement Penalty Uncertain

Executive Summary

Gilead is appealing a jury finding that it must pay Merck 10% royalty on sales of Sovaldi and Harvoni through August 2016; judge could find the firm owes treble the amount for willful infringement.

Advertisement

Related Content

Merck's Write-Down Of Phase II Nuc Illustrates Current Reality In HCV
PSCK9 Battle: Sanofi Not Negotiating Praluent Fate With Amgen; Ruling Possible By June
Brand vs. Brand Patent Battles Heat Up, Focus On Big Drug Classes
HCV Patent Case: With "Unclean Hands," Merck Can't Collect Jury Award From Gilead
Merck Gets $200m In Gilead Patent Case, But Who Wins?
Legal News, In Brief: FDA Opposes Otsuka Suit; Apotex Can Challenge Benicar Patent
Lilly Laid Groundwork For Abbott's Defeat Of J&J's Patent Verdict On Humira

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS119695

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel